Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders
Jingwei Song, Ruchit V. Patel, Massoud Sharif, et al.
Molecular Therapy (2021) Vol. 30, Iss. 3, pp. 990-1005
Open Access | Times Cited: 21

Showing 21 citing articles:

Gene therapy for CNS disorders: modalities, delivery and translational challenges
Jingjing Gao, Swetharajan Gunasekar, Ziting Xia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 8, pp. 553-572
Closed Access | Times Cited: 19
Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo
Viktoriya G. Krut’, Andrei L. Kalinichenko, Dmitry I. Maltsev, et al.
Progress in Neurobiology (2024) Vol. 235, pp. 102600-102600
Closed Access | Times Cited: 9
Validation of DREADD agonists and administration route in a murine model of sleep enhancement
Loris L. Ferrari, Oghomwen Igiesuorobo, Heinrich S. Gompf, et al.
Journal of Neuroscience Methods (2022) Vol. 380, pp. 109679-109679
Open Access | Times Cited: 29
Application of Optogenetics in Neurodegenerative Diseases
Qian Zhang, Tianjiao Li, Mengying Xu, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 6
Next generation technologies for diagnosis
Arlene Astell, Tamlyn Watermeyer, James Semple
Elsevier eBooks (2025), pp. 265-288
Closed Access
A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
Kate A. Lawson, Christina M. Ruiz, Stephen V. Mahler
Psychopharmacology (2023) Vol. 240, Iss. 10, pp. 2101-2110
Open Access | Times Cited: 12
Neural circuit-selective, multiplexed pharmacological targeting of prefrontal cortex-projecting locus coeruleus neurons drives antinociception
Chao‐Cheng Kuo, Jordan G. McCall
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 4
Alteration of Neural Pathways and Its Implications in Alzheimer’s Disease
Sujin Kim, Yunkwon Nam, Hyeon soo Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 845-845
Open Access | Times Cited: 16
Ultrasound-Enabled Nanomedicine for Tumor Theranostics
Kairui Liu, Boyuan Jing, Jun Kang, et al.
Engineering (2024)
Open Access | Times Cited: 3
PET reporter systems for the brain
Sridhar Goud Nerella, Michel Michaelides, Takafumi Minamimoto, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 11, pp. 941-952
Open Access | Times Cited: 8
Synthesis and preclinical evaluation of [11C]uPSEM792 for PSAM4-GlyR based chemogenetics
Sridhar Goud Nerella, Sanjay Telu, Jeih‐San Liow, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Unraveling the Neural Circuits: Techniques, Opportunities and Challenges in Epilepsy Research
Wenjie Xiao, Peile Li, Fujiao Kong, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Translating Molecular Approaches to Oligodendrocyte-Mediated Neurological Circuit Modulation
Jingwei Song, Aybike Saglam, J. Bradley Zuchero, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 648-648
Open Access | Times Cited: 2
The use of chemogenetic actuator ligands in nonhuman primate DREADDs-fMRI
Adriana K. Cushnie, Daniel Bullock, Ana M.G. Manea, et al.
Current Research in Neurobiology (2022) Vol. 4, pp. 100072-100072
Open Access | Times Cited: 11
What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
S Hashimoto, Atsushi Fujimoto, Catherine Elorette, et al.
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 184-195
Closed Access | Times Cited: 1
The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling
Yu Hu, Hao Li, Hongwei Zhang, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4749-4757
Open Access | Times Cited: 5
A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
Kate A. Lawson, Christina M. Ruiz, Stephen V. Mahler
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Strength of Activation and Temporal Dynamics of BioLuminescent-Optogenetics in Response to Systemic Injections of the Luciferin
Emily F. Murphy, Aniya Means, Chen Li, et al.
NeuroImage (2024), pp. 120882-120882
Open Access
Strength of Activation and Temporal Dynamics of BioLuminescent-Optogenetics in Response to Systemic Injections of the Luciferin
Emily F. Murphy, Aniya Means, Chen Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neuronal Activity in Brain Tumor Pathogenesis: Adding to the Complexities of Central Nervous System Neoplasia
Khushboo Irshad, Nicole M Brossier, Yuan Pan
Springer eBooks (2023), pp. 3-25
Closed Access
Page 1

Scroll to top